FIRST TRUST NASDAQ PHARMACEUTICALS ETF Forecast

FIRST TRUST NASDAQ PHARMACEUTICALS ETF price down 0.259% on Wednesday
(Updated on May 08, 2024)

FTXH Signals & Forecast

The FIRST TRUST NASDAQ PHARMACEUTICALS ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the ETF has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $26.56 and $26.74. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 3.81%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. FIRST TRUST NASDAQ PHARMACEUTICALS gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The ETF had a Golden Star Signal on Tuesday, July 18, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Support, Risk & Stop-loss for FIRST TRUST NASDAQ PHARMACEUTICALS ETF

FIRST TRUST NASDAQ PHARMACEUTICALS finds support from accumulated volume at $26.46 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the ETF moved $0.110 between high and low, or 0.411%. For the last week the ETF has had daily average volatility of 0.407%.

Our recommended stop-loss: $25.66 (-4.10%) (This ETF has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (FTXH) For The Upcoming Trading Day Of Thursday 9th

For the upcoming trading day on Thursday, 9th we expect FIRST TRUST NASDAQ PHARMACEUTICALS ETF to open at $26.78, and during the day (based on 14 day Average True Range), to move between $26.55 and $26.98, which gives a possible trading interval of +/-$0.214 (+/-0.80%) up or down from last closing price. If FIRST TRUST NASDAQ PHARMACEUTICALS ETF takes out the full calculated possible swing range there will be an estimated 1.60% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $26.46 (1.13%) than the resistance at $27.73 (3.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is FIRST TRUST NASDAQ PHARMACEUTICALS ETF ETF A Buy?

FIRST TRUST NASDAQ PHARMACEUTICALS holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.666 Hold/Accumulate Unchanged

Predicted Opening Price for FIRST TRUST NASDAQ PHARMACEUTICALS ETF of Thursday, May 9, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.